LANDSCAPE OF TARGETABLE BRAF ALTERATIONS AND RAF1 FUSIONS IN PEDIATRIC MALIGNANCY

被引：0
|
作者：
Rankin, Andrew [1 ]
Johnson, Adrienne [1 ]
Rosenzweig, Mark [1 ]
Knipstein, Jeffrey [1 ]
Kannan, Geoffrey [1 ]
Britt, Nicholas [1 ]
Pavlick, Dean [1 ]
Vergilio, Jo-Anne [1 ]
Severson, Eric [1 ]
Erlich, Rachel [1 ]
Squillace, Rachel [1 ]
Stephens, Phil [1 ]
Miller, Vince [1 ]
Ross, Jeffrey [1 ]
Ramkissoon, Shakti [1 ]
Ali, Siraj [1 ]
机构：
[1] Fdn Med Inc, Cambridge, MA USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
801
引用
收藏
页数：2
相关论文
共 45 条
  • [1] Landscape of RAF1 fusions in solid tumors and therapeutic utility of sorafenib
    Mehnert, J.
    Ali, S.
    Kulkarni, A.
    Pavlick, D.
    Goydos, J.
    Chen, S.
    Shrock, A.
    Hirshfield, K.
    Rodriguez, L.
    Stein, M.
    White, E.
    Ross, J.
    Miller, V.
    Stephens, P.
    Ganesan, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S142 - S142
  • [2] Landscape of BRAF and RAF1 fusions identified by next-generation sequencing in a Chinese multi-cancer retrospective analysis
    Li, Tao
    Zhang, Xin
    Niu, Yanling
    Ma, Tonghui
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Recurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas
    Benhamida, Jamal K. K.
    Harmsen, Hannah J. J.
    Ma, Deqin
    William, Christopher M. M.
    Li, Bryan K. K.
    Villafania, Liliana
    Sukhadia, Purvil
    Mullaney, Kerry A. A.
    Dewan, Michael C. C.
    Vakiani, Efsevia
    Karajannis, Matthias A. A.
    Snuderl, Matija
    Zagzag, David
    Ladanyi, Marc
    Rosenblum, Marc K. K.
    Bale, Tejus A. A.
    BRAIN PATHOLOGY, 2023,
  • [4] Truncation of BRAF and Raf1 in prostate cancer in China
    Lu, Yong-Jie
    Liu, Xiaoyan
    Mao, Xueying
    Hylands, Lucy
    Clark, Jeremy
    Cooper, Colin
    Ren, Guoping
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [5] Frequent CD30 Expression in an Emerging Group of Mesenchymal Tumors With NTRK, BRAF, RAF1, or RET Fusions
    Kojima, Naoki
    Mori, Taisuke
    Motoi, Toru
    Kobayashi, Eisuke
    Yoshida, Masayuki
    Yatabe, Yasushi
    Ichikawa, Hitoshi
    Kawai, Akira
    Yonemori, Kan
    Antonescu, Cristina R.
    Yoshida, Akihiko
    MODERN PATHOLOGY, 2023, 36 (04)
  • [6] Targeting RAF1 gene fusions with MEK inhibition in metastatic melanoma
    Khaddour, Karam
    Haq, Rizwan
    Buchbinder, Elizabeth, I
    Liu, David
    Manos, Michael P.
    Ott, Patrick A.
    Hodi, F. Stephen
    Insco, Megan L.
    ONCOLOGIST, 2024,
  • [7] Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles
    Williams, Erik A.
    Shah, Nikunj
    Montesion, Meagan
    Sharaf, Radwa
    Pavlick, Dean C.
    Sokol, Ethan S.
    Alexander, Brian M.
    Venstrom, Jeff M.
    Elvin, Julia A.
    Ross, Jeffrey S.
    Tse, Julie Y.
    Mochel, Mark C.
    MODERN PATHOLOGY, 2020, 33 (08) : 1466 - 1474
  • [8] NOVEL BRAF FUSION GENE AND CHARACTERIZATION OF BRAF AND RAF1 BREAKPOINTS IN PILOCYTIC ASTROCYTOMA
    Cin, H.
    Meyer, C.
    Witt, H.
    Remke, M.
    Janzarik, W.
    Van Anh, T.
    Olbrich, H.
    von Deimling, A.
    Kulozik, A. E.
    Marschalek, R.
    Witt, O.
    Omrans, H.
    Lichter, P.
    Korshunov, A.
    Pfister, S. M.
    NEURO-ONCOLOGY, 2010, 12 (06) : II22 - II23
  • [9] RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα
    Varga, Andrea
    Ehrenreiter, Karin
    Aschenbrenner, Bertram
    Kocieniewski, Pawel
    Kochanczyk, Marek
    Lipniacki, Tomasz
    Baccarini, Manuela
    SCIENCE SIGNALING, 2017, 10 (469)
  • [10] Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
    Sievert, Angela J.
    Lang, Shih-Shan
    Boucher, Katie L.
    Madsen, Peter J.
    Slaunwhite, Erin
    Choudhari, Namrata
    Kellet, Meghan
    Storm, Phillip B.
    Resnick, Adam C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (15) : 5957 - 5962
12345